Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

Archive for October 2014

Flu Shots Highly Recommended for Mesothelioma Patients and Their Families

Almost everywhere you look, health care advocates are pushing the public to get immunized against flu shots. Parents of young children, the children themselves, and the elderly are all being urged to protect themselves from the harsh impact of influenza, and the benefits of herd immunity are being reported on national news. Every pharmacy, supermarket…

Read More

Report Indicates that Spain is Under-Reporting Incidence of Mesothelioma

One of the most important aspects of coming up with appropriate and timely responses to a mesothelioma diagnosis is the prompt diagnosis of the disease, and from a public health perspective, it is equally important that government health agencies acknowledge that the condition is present. In Spain, health care advocates are expressing concern following a…

Read More

Verastem Presents Findings at International Conference

Attendees at the 12 International Mesothelioma Interest Group Conference, being held at the Cape Town International Conference Centre in Cape Town, South Africa, heard encouraging news from representatives of Verastem, Inc. regarding some of their clinical and preclinical trial results. Verastem is a drug manufacturer that specifically focuses on the discovery and development of drugs…

Read More

Australian Doctors Warn Against Rushing to Radiation of Needle-Site Tumors

A study conducted by Australian researchers has warned against the dangers of physicians assuming that every tumor in a mesothelioma patient is malignant. In a study published in the October issue of Journal of Bronchology and Interventional Pulmonology chronicles the fact that when doctors suspect that a patient has pleural mesothelioma, needle biopsies are often…

Read More

Blood Pressure Drug Shows Promise For Mesothelioma Treatment

A popular blood pressure medication that has been used in the treatment of a variety of other conditions is now showing promise in the treatment of malignant pleural mesothelioma. Researchers in Japan have indicated that they have been studying the impact of naftopidil for several years and have high hopes for its future. Naftopidil is…

Read More

Cancer Study Finds Source of Energy That Drives Metastases

Cancer researchers and patients alike know that one of the most difficult aspects of treating cancer lies in the way that the disease can travel from its original location to other areas of the body. When cancer is first diagnosed, one of the very first things that doctors do is to determine whether it is…

Read More

Researchers Boost Chemotherapy Impact for Mesothelioma Patients

Researchers Boost Chemotherapy Impact for Mesothelioma Patients A team of scientists working to find a way to make malignant mesothelioma tumor cells more sensitive to chemotherapy believe that they have found a way, and the answer lies in a specific estrogen receptor. The researchers hail from two different universities in Europe. A group of pharmaceutical…

Read More

Experts Encourage Mesothelioma Patients to Participate in Clinical Trials

One of the most important decisions that a person who has been diagnosed with mesothelioma must make is whether or not to participate in one of the many clinical trials investigating new treatment approaches and therapies for the disease. Many view these trials as an opportunity to participate in the discovery of new weapons against…

Read More

New Study Questions Benefits of Radiation Therapy

The results of a new study have been released at the European Society for Medical Oncology (ESMO) Congress 2014, held in Madrid, and they reveal that high-dose radiotherapy adds no significant survival benefit following radical surgery and chemotherapy treatments. The results represent a disappointment to researchers, physicians and patients alike. According to current ESMO president…

Read More